简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-10-12 15:19 Immetas Therapeutics and GC Biopharma Announce Research Collaboration to Discover and Develop mRNA Therapeutics to Treat Autoimmune Diseases
2023-10-12 11:00 Empowering Colombia's Future Through Education; ADFD's Commitment to Colombia's Early Childhood Development
2023-10-12 10:22 Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action in Atopic Dermatitis and Prurigo Nodularis
2023-10-12 08:59 SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
2023-10-12 08:52 Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China
2023-10-11 14:55 Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS
2023-10-11 08:44 Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
2023-10-10 14:40 Merck Presents New MAVENCLAD® (Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation
2023-10-10 14:09 FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System
2023-10-10 13:28 Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
2023-10-08 16:09 Phase III Studies to Investigate Survodutide for People Living with Obesity and Overweight, with and without Diabetes, Cardiovascular Disease and Chronic Kidney Disease
2023-10-08 14:13 Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years
2023-10-08 10:34 RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
2023-10-07 16:11 Takeda Provides Update on EXKIVITY® (mobocertinib)
2023-10-07 12:17 TDCX Grows in Europe With Two New Healthtech Clients
2023-10-07 11:52 The Estée Lauder Companies Launches 2023 Breast Cancer Campaign: Beautifully United to Help End Breast Cancer
2023-10-07 10:50 EADV 2023: Galderma to Present New Data Showcasing Its Continued Leadership in Dermatology
2023-10-07 10:45 Galderma announces progress with RelabotulinumtoxinA regulatory submissions
2023-10-07 10:43 Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss
2023-09-27 16:11 Korean Unicorn APR Files for Preliminary IPO Review on KRX